mTor: An Important Pathway in Targeting Cancer

 
Wyeth May, 2007
 

In the ever-evolving field of cancer research, the understanding of potential new anti-cancer compounds is critical. In order for physicians to quickly learn and understand the mechanism of action of a key kinase, rapamycin (known as mTOR) which has become a focal point in anti-cancer pathway research, we utilized 3D animation to educate physicians about this highly complex, promising new pathway.

Agency Partner: Saatchi & Saatchi Healthcare Innovations
Awards: 3 Tellys, 1 Rx Club, Global Award Finalist